2Shiha G, EL-Sayed SS. Gastric variceal ligation: a new technique.Gastrointest Endosc, 1999,49 : 437-441.
3Sarin SK, Kumar A. Sclerosants for variceal sclerotherapy: a critical appraisal. Am J Gastroenterol , 1990,85:641-649.
4Bhargava DK, Singh B,Dogra R,et al. Prospective randomized comparison of STD and polidocanol as variceal sclerosing agents. Am J Gastroenterol, 1992,87 : 182-186.
5Lo GH Lai KH, Cheng JS, et al. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial. Hepatology, 1998,28:391-395.
6Bhasin DK, Malhi NJ. Variceal bleeding and portal hypertension:much to learn, much to explore. Endoscopy ,2002,34 : 119-128.
7Huang YH, Yeh HE, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by n-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc ,2000,52:160-167.
8Kitano S, Koyanagi N, Iso Y, et al. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology,1987,7: 810-815.
9Schuman MB, Beckman JM, Tedesco FJ, et al. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol,1987,82: 823-830.
10Kang HK, Jeong YY, Choi JH, et al. Three-dimensional multi-detector row CT portal venography in the evaluation of portosystemic.collateral vessels in liver cirrhosis. Radiographics,2002, 22: 1053-1061.